UGCG and neoplasm: In line, we have previously shown that the direct targeting of Ugcg in murine hepatocytes or treatment with the specific GCS-inhibitor Genz-123346 led to the absence or reduction in GSLs and inhibited tumor growth in mouse models of chemically induced hepatocellular and colorectal cancer [20,21].